drugset / Trial / NCT00262184
A Taiwan Isoflavone Multicenter Study (TIMS)
Unknown
420 enrolled
National Health Research Institutes, Taiwan
Genovate Biotechnology Co., Ltd., · collabTaiwan Biotech Co., Ltd. · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Consumption of soy-based foods is associated with a number of health benefits, including lower risk of cardiovascular disease, breast and prostate cancer, attenuated menopausal symptoms and prevention of bone loss with age. In order to investigate the effect of isoflavone on bone mineral density (BMD) and in Taiwan women with postmenopausal osteopenia, a Taiwan Isoflavone Multicentric Enrollment Study (TIMS) is designed.
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soy Isoflavone | Unknown | 300 mg | Oral |